Veru Inc. submits 10-K Annual Report to SEC online.

Veru Inc., a pharmaceutical company specializing in the development and commercialization of oncology and urology medicines, has submitted its 10-K Annual Report to the SEC for the period ending September 30, 2024. This filing provides detailed financial information and operational insights into the company’s performance over the past year, offering investors and stakeholders a comprehensive view of Veru Inc.’s business activities and prospects.

Attachments:
1. FORM 10-K – View the full 10-K report filed by Veru Inc.
2. EXHIBIT 19 – Access Exhibit 19 associated with the filing.
3. EXHIBIT 21 – Explore Exhibit 21 providing additional information about Veru Inc.

Other Relevant Information:
– Veru Inc. operates in the pharmaceutical preparations industry, with a focus on oncology and urology treatments.
– The company’s business and mailing address are both located at 2916 N. Miami Avenue, Suite 1000, Miami, FL 33127.
– Contact phone number for Veru Inc.: 312-595-9123.
– IRS Number: 391144397 | State of Incorporation: Wisconsin | Fiscal Year End: September 30.
– Filing Type: 10-K | SEC Act: 34 | File Number: 001-13602 | Film Number: 241551688.
– Standard Industrial Classification (SIC): 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences).

For more details and to access the complete submission text file, refer to the original filing on the SEC website.